查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585667

生物義肢市場：按類型、應用分類 - 2025-2030 年全球預測

Bioprosthetics Market by Type (Allograft, Bovine, Porcine), Application (Cardiovascular, Plastic Surgery & Wound Healing) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物義肢市場價值為59.7億美元，預計2024年將達到71.4億美元，複合年成長率為19.61%，到2030年將達到209.4億美元。

生物假體包括由生物材料製成的醫療植入部分，旨在替換或修復受損的組織或器官。這種需求源自於退化性疾病、創傷和先天缺陷等問題，導致人們需要比傳統材料更相容且更不易排斥的替代品。應用主要包括心血管手術，特別是心臟瓣膜、疝氣修復和其他軟組織重組。最終使用領域包括醫院、專科診所和門診手術中心，其中的挑戰始終是透過先進的手術選擇來改善病患的治療效果。主要成長動力包括心血管疾病盛行率的增加、生物相容性的進步以及人口老化。由於對醫療基礎設施發展的日益關注以及患者對先進治療方案的認知，新興市場具有巨大潛力。然而，與生物材料的使用相關的高成本、嚴格的法規環境和倫理問題等限制因素可能會阻礙市場的進步。同樣具有挑戰性的是開發人員必須克服合成替代品日益激烈的競爭和技術限制。組織工程、提高材料的生物相容性以及整合數位健康工具的組合設備等領域的創新可以為業務成長提供利潤豐厚的機會。提高耐久性和降低免疫抗原性的研究對於擴大市場接受度和適用性至關重要。市場本質上是動態的，受到全球監管變化和技術進步的推動。公司應投資於尖端生物修復解決方案的研發，並與醫療保健提供者合作，以確保產品符合當前和新興的需求。透過臨床試驗提高意識並證明安全性和有效性是鞏固市場地位的重要策略。

主要市場統計
基準年[2023] 59.7億美元
預測年份 [2024] 71.4億美元
預測年份 [2030] 209.4億美元
複合年成長率（%） 19.61%

市場動態：揭示快速發展的生物修復市場的關鍵市場洞察

供需的動態交互作用正在改變生物義肢市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 人群中心血管疾病盛行率上升
    • 各國醫療保健支出增加
    • 生物義肢在整形外科和創傷治療過程中的重要應用
  • 市場限制因素
    • 生物假體手術相關的高成本
  • 市場機會
    • 組織工程生物假體的技術進步與快速發展
    • 新的資金籌措活動促進研發活動
  • 市場挑戰
    • 閥門耐用性和相容性問題

波特的五力：駕馭生物義肢市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物義肢市場的外部影響

外部宏觀環境因素在塑造生物義肢市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解生物義肢市場的競爭狀況

對生物義肢市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣生物義肢市場供應商績效評估

FPNV定位矩陣是評估生物義肢市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了生物義肢市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對生物義肢市場進行策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群中心血管疾病盛行率上升
      • 經濟體中的醫療成本增加
      • 生物義肢在整形外科手術和創傷治療過程中的重要應用
    • 抑制因素
      • 生物假體手術相關的高成本
    • 機會
      • 組織工程人工替代物體的技術進步與快速發展
      • 新的資金籌措努力促進研發活動
    • 任務
      • 閥門耐用性和相容性問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章生物義肢市場：依類型

  • 同種異體移植
  • 牛
  • 豬肉
  • 異種移植

第7章生物義肢市場：依應用分類

  • 心血管
  • 整形外科和創傷治療

第8章北美和南美生物修復市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區生物修復市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的生物義肢市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Anteris Technologies Ltd.
  • Aortech International PLC
  • Boston Scientific Corporation
  • Braile Biomedica, Inc.
  • Corcym UK Limited
  • Edwards Lifesciences Corporation
  • Foldax
  • Getinge AB
  • Hancock Jaffe Laboratories, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular Inc.
  • Life Cell Corporation
  • LifeNet Health
  • LivaNova, PLC
  • Medical Devices Business Services, Inc.
  • Medtronic PLC
  • Organogenesis, Inc.
  • Sorin Group
  • Suzhou Jiecheng Medical Technology Co., Ltd
  • Ziacom Medical
Product Code: MRR-3E42F39F1CF4

The Bioprosthetics Market was valued at USD 5.97 billion in 2023, expected to reach USD 7.14 billion in 2024, and is projected to grow at a CAGR of 19.61%, to USD 20.94 billion by 2030.

Bioprosthetics encompass a segment of medical implants made from biological materials, designed to replace or repair damaged tissues or organs. Their necessity arises from issues like degenerative diseases, trauma, and congenital defects, leading to the demand for more compatible and less rejection-prone substitutes compared to traditional materials. Applications primarily include cardiovascular surgeries, particularly heart valves, hernia repair, and other soft tissue reconstructions. The end-use sectors are vast, spanning hospitals, specialty clinics, and ambulatory surgical centers, which are continually challenged to improve patient outcomes with advanced surgical options. Key growth drivers include the increasing prevalence of cardiovascular diseases, advancements in biocompatibility, and the aging population, which is more prone to conditions requiring such interventions. Emerging markets offer enormous potential due to an increasing focus on healthcare infrastructure development and rising patient awareness about advanced treatment options. However, limitations such as high costs, stringent regulatory environments, and ethical concerns related to the use of biological materials can hamper market progress. Challenges also stem from intense competition and technological constraints in synthetic alternatives that developers must surpass. Innovating in areas like tissue engineering, enhanced materials biocompatibility, and combination devices integrating digital health tools can provide lucrative opportunities for business growth. Research in improving durability and reducing immunogenicity is crucial for expanding market acceptance and applicability. The market is inherently dynamic, driven by regulatory shifts and technological advancements globally. Companies should invest in R&D for cutting-edge bioprosthetic solutions and collaborate with healthcare providers to ensure that products meet current and emerging needs. Building awareness and proving safety and efficacy through clinical trials are essential strategies to fortify market position.

KEY MARKET STATISTICS
Base Year [2023] USD 5.97 billion
Estimated Year [2024] USD 7.14 billion
Forecast Year [2030] USD 20.94 billion
CAGR (%) 19.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioprosthetics Market

The Bioprosthetics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cardiovascular diseases among population
    • Increase in healthcare expenditure in economies
    • Significant applications of bioprosthetics in plastic surgery & wound healing procedures
  • Market Restraints
    • High costs associated with bioprosthetic surgeries
  • Market Opportunities
    • Technological advancement and rapid evolution of tissue-engineered bioprostheses
    • Emerging funding activities to boost research and development activities
  • Market Challenges
    • Issues pertaining to valve durability and compatibility

Porter's Five Forces: A Strategic Tool for Navigating the Bioprosthetics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioprosthetics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioprosthetics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioprosthetics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioprosthetics Market

A detailed market share analysis in the Bioprosthetics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioprosthetics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioprosthetics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioprosthetics Market

A strategic analysis of the Bioprosthetics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioprosthetics Market, highlighting leading vendors and their innovative profiles. These include Anteris Technologies Ltd., Aortech International PLC, Boston Scientific Corporation, Braile Biomedica, Inc., Corcym UK Limited, Edwards Lifesciences Corporation, Foldax, Getinge AB, Hancock Jaffe Laboratories, Inc., Humacyte, Inc., JenaValve Technology GmbH, Labcor Laboratorios Ltd., LeMaitre Vascular Inc., Life Cell Corporation, LifeNet Health, LivaNova, PLC, Medical Devices Business Services, Inc., Medtronic PLC, Organogenesis, Inc., Sorin Group, Suzhou Jiecheng Medical Technology Co., Ltd, and Ziacom Medical.

Market Segmentation & Coverage

This research report categorizes the Bioprosthetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Allograft, Bovine, Porcine, and Xenograft.
  • Based on Application, market is studied across Cardiovascular and Plastic Surgery & Wound Healing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cardiovascular diseases among population
      • 5.1.1.2. Increase in healthcare expenditure in economies
      • 5.1.1.3. Significant applications of bioprosthetics in plastic surgery & wound healing procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with bioprosthetic surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement and rapid evolution of tissue-engineered bioprostheses
      • 5.1.3.2. Emerging funding activities to boost research and development activities
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to valve durability and compatibility
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bioprosthetics Market, by Type

  • 6.1. Introduction
  • 6.2. Allograft
  • 6.3. Bovine
  • 6.4. Porcine
  • 6.5. Xenograft

7. Bioprosthetics Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular
  • 7.3. Plastic Surgery & Wound Healing

8. Americas Bioprosthetics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Bioprosthetics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Bioprosthetics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anteris Technologies Ltd.
  • 2. Aortech International PLC
  • 3. Boston Scientific Corporation
  • 4. Braile Biomedica, Inc.
  • 5. Corcym UK Limited
  • 6. Edwards Lifesciences Corporation
  • 7. Foldax
  • 8. Getinge AB
  • 9. Hancock Jaffe Laboratories, Inc.
  • 10. Humacyte, Inc.
  • 11. JenaValve Technology GmbH
  • 12. Labcor Laboratorios Ltd.
  • 13. LeMaitre Vascular Inc.
  • 14. Life Cell Corporation
  • 15. LifeNet Health
  • 16. LivaNova, PLC
  • 17. Medical Devices Business Services, Inc.
  • 18. Medtronic PLC
  • 19. Organogenesis, Inc.
  • 20. Sorin Group
  • 21. Suzhou Jiecheng Medical Technology Co., Ltd
  • 22. Ziacom Medical

LIST OF FIGURES

  • FIGURE 1. BIOPROSTHETICS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPROSTHETICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPROSTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOPROSTHETICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOPROSTHETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPROSTHETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPROSTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPROSTHETICS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPROSTHETICS MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPROSTHETICS MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPROSTHETICS MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PLASTIC SURGERY & WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. BIOPROSTHETICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. BIOPROSTHETICS MARKET, FPNV POSITIONING MATRIX, 2023